Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIV Effectiveness in Senegalese Children
NCT00893906Phase 4Completed
- Sponsor
- PATH
- Start
- May 2009
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine in influenza, sponsored by PATH. Started May 2009; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00893906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00893906.